Drs. Ibilibor and Stratton preview research from the 2022 Genitourinary Cancers Symposium.
EP. 1: 2022 ASCO GU Overview: Dr. Ibilibor on metastatic UC, RCC, and rare cancers
Christine Ibilibor, MD, discusses 6 noteworthy abstracts from the 2022 Genitourinary Cancers Symposium.
EP. 2: 2022 ASCO GU Overview: Dr. Stratton highlights top prostate cancer abstracts
Kelly L. Stratton, MD, FACS, highlights 5 pivotal prostate cancer studies from the 2022 ASCO Genitourinary Cancers Symposium.
NIAGARA: ctDNA analysis highlights durvalumab’s impact in MIBC
Nivolumab/ipilimumab continues to show improved survival, durable response in aRCC
Mixed results reported for nivolumab/ipilimumab in cisplatin-ineligible mUC
EV plus pembrolizumab doubles CR rate vs chemotherapy in la/mUC
